Nelarabine - NDC Database

13 records found
Page:1
14789-114 Dec 26, 2023
Nelarabine 5 mg/ml Intravenous Injection by Nexus Pharmaceuticals LLC
25021-259 Aug 01, 2024
Nelarabine 5 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
43598-142 Jan 09, 2023
Nelarabine 5 mg/ml Intravenous Injection by Dr. Reddy's Laboratories, Inc.
46708-813 Aug 01, 2024
Nelarabine 5 mg/ml Intravenous Injection by Alembic Pharmaceuticals Limited
62332-813 Aug 01, 2024
Nelarabine 5 mg/ml Intravenous Injection by Alembic Pharmaceuticals Inc.
68083-233 Jan 03, 2024
Nelarabine 5 mg/ml Intravenous Injection by Gland Pharma Limited
70121-1743 Apr 10, 2023
Nelarabine 5 mg/ml Intravenous Injection by Amneal Pharmaceuticals LLC
70710-1726 Nov 17, 2021
Nelarabine 5 mg/ml Intravenous Injection by Zydus Pharmaceuticals (Usa) Inc.
70710-1839 Jun 24, 2022
Nelarabine 5 mg/ml Intravenous Injection by Zydus Pharmaceuticals USA Inc.
70771-1685 Nov 17, 2021
Nelarabine 5 mg/ml Intravenous Injection by Cadila Healthcare Limited
71288-165 Jan 10, 2023
Nelarabine 5 mg/ml Intravenous Injection by Meitheal Pharmaceuticals Inc
80978-111 Apr 12, 2023
Nelarabine 250 mg/ml Intravenous Injection by Aqvida Gmbh
81927-111 Mar 15, 2023
Nelarabine 5 mg/ml Intravenous Injection by Shorla Oncology Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.